← FDA DRUG APPROVALS

FDA ANDA · ANDA089537

PROCAINAMIDE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA089537
TYPE
ANDA
ORIGINAL APPROVAL
2004-07-29
LATEST ACTION
2004-07-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PROCAINAMIDE HYDROCHLORIDEDiscontinued
PROCAINAMIDE HYDROCHLORIDE 500MG/ML · INJECTABLE · INJECTION

Approval history

2004-07-29OriginalAP
2001-02-14Manufacturing (CMC) · Supplement 7AP
1995-12-22Manufacturing (CMC) · Supplement 6AP
1992-06-26Labeling · Supplement 4AP
1990-11-30Manufacturing (CMC) · Supplement 3AP
1989-07-06Manufacturing (CMC) · Supplement 2AP
1989-02-03Labeling · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →